BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18/06/2018

FDA Announces Draft Guidance for Developing Drugs for Epidermolysis Bullosa

The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for the skin symptoms of epidermolysis bullosa, a rare genetic disorder with limited treatment options.

Source: Federal Register — Food and Drug AdministrationOpen original release →